Rare benign ovarian tumor
rayr bee-nine oh-VAIR-ee-an TOO-mer
Also known as: Ovarian lipoleiomyoma, Ovarian sclerosing stromal tumor
At a Glance
What is Rare benign ovarian tumor?
Rare benign ovarian tumors are non-cancerous growths that occur in the ovaries, which are part of the female reproductive system. These tumors can vary in size and type, with some being composed of fatty, fibrous, or muscular tissue. They are often discovered incidentally during imaging for other conditions, as they may not cause symptoms initially. Over time, they may grow and cause symptoms such as abdominal pain, bloating, or changes in menstrual cycles. Early symptoms can be subtle, but as the tumor enlarges, it may lead to more noticeable discomfort or pressure in the pelvic area. Early diagnosis is crucial to differentiate these benign tumors from malignant ones, which require different treatment approaches. The presence of a benign ovarian tumor can be stressful for families due to concerns about potential malignancy. However, the prognosis for benign tumors is generally excellent, with surgical removal often being curative. Daily life for individuals with these tumors can be normal, although regular monitoring may be necessary. Treatment typically involves surgical intervention, especially if the tumor causes symptoms or is suspected to be malignant. Post-surgery, most individuals recover fully and can resume their usual activities without significant limitations.
Medical Definition
Rare benign ovarian tumors are non-malignant neoplasms that arise from ovarian tissues, including stromal, epithelial, or germ cell components. Histologically, these tumors may exhibit a variety of cell types, such as lipoleiomyomas containing adipose and smooth muscle tissue, or sclerosing stromal tumors characterized by cellular and collagenous stroma. They are classified under benign ovarian neoplasms and are distinct from malignant ovarian cancers. Epidemiologically, these tumors are uncommon, with a prevalence estimated at approximately 1 in 500,000 women. The disease course is typically indolent, with slow growth and low potential for complications. Management often involves surgical excision, which is curative in the majority of cases, and the overall prognosis is favorable.
Rare benign ovarian tumor Symptoms
Symptoms vary in severity between individuals. Early diagnosis and management can significantly improve outcomes.
Very Common
Abdominal pain manifests as a persistent or intermittent discomfort in the lower abdomen. It is caused by the pressure exerted by the growing tumor on surrounding tissues and organs. Over time, the pain may become more frequent and intense as the tumor increases in size. This symptom can significantly affect daily activities, and pain management strategies such as medication or surgical intervention may be necessary.
A pelvic mass is often detected during a routine pelvic examination or imaging studies. It results from the physical presence of the tumor within the pelvic cavity. As the tumor grows, it may become palpable and cause a sensation of fullness or heaviness in the pelvic area. Regular monitoring and imaging can help assess the growth and guide treatment decisions.
Menstrual irregularities can present as changes in cycle length, flow, or frequency. These changes are due to hormonal imbalances caused by the tumor's impact on ovarian function. Over time, these irregularities may become more pronounced, leading to concerns about fertility and overall reproductive health. Hormonal therapies or surgical options may be considered to manage these symptoms.
Common
Bloating is experienced as a sensation of fullness or swelling in the abdomen. It occurs due to the accumulation of fluid or gas as the tumor exerts pressure on the digestive tract. Over time, bloating can become more persistent and uncomfortable, affecting dietary habits and physical comfort. Dietary modifications and medications may help alleviate this symptom.
Urinary frequency is characterized by an increased need to urinate more often than usual. This symptom is caused by the tumor pressing against the bladder, reducing its capacity. As the tumor grows, the frequency of urination may increase, leading to disruptions in daily activities and sleep. Strategies such as bladder training and surgical intervention may be necessary to manage this symptom.
Constipation presents as infrequent or difficult bowel movements. It is caused by the tumor's pressure on the intestines, which can impede normal bowel function. Over time, constipation may lead to discomfort and require dietary changes or laxatives for relief. Addressing this symptom is important for maintaining digestive health and comfort.
Less Common
Nausea is a sensation of unease and discomfort in the stomach, often accompanied by an urge to vomit. It can result from the tumor's impact on the digestive system and hormonal changes. Over time, nausea may become more frequent and affect appetite and nutrition. Antiemetic medications and dietary adjustments can help manage this symptom.
Weight gain may occur as a result of the tumor's growth and associated fluid retention. The biological mechanism involves changes in metabolism and hormonal balance. Over time, weight gain can affect self-esteem and physical health, necessitating lifestyle modifications. Monitoring weight and implementing dietary and exercise plans can help manage this symptom.
What Causes Rare benign ovarian tumor?
The development of rare benign ovarian tumors is not typically linked to a single causative gene, but rather involves a complex interplay of genetic and environmental factors. While specific genes have not been definitively identified, research suggests that mutations in genes regulating cell growth and differentiation may play a role. These genes are often located on chromosomes that are involved in ovarian tissue development and maintenance. The normal function of these genes is to encode proteins that regulate the cell cycle, apoptosis, and cellular adhesion. Mutations may lead to the production of dysfunctional proteins that fail to properly regulate these processes, resulting in uncontrolled cell proliferation. This can cause an accumulation of abnormal cells, leading to the formation of benign tumors. Inside the cell, these mutations can disrupt normal signaling pathways, such as the PI3K/AKT pathway, which is crucial for cell survival and growth. This disruption can lead to organelle dysfunction, particularly affecting the mitochondria and endoplasmic reticulum, which are vital for energy production and protein folding, respectively. The downstream effects on neighboring cells and tissues include altered communication and nutrient exchange, contributing to the tumor microenvironment. Neuroinflammation and immune responses may be triggered as the body attempts to eliminate the abnormal cells, although these responses are typically less pronounced in benign conditions compared to malignant ones. Over time, the structural integrity of ovarian tissue may be compromised, although white matter degeneration is not a feature of these tumors. Symptoms appear in a specific pattern due to the tumor's location and size, often causing abdominal pain or menstrual irregularities. Disease severity varies between patients due to differences in genetic background, tumor size, and location, as well as individual responses to cellular stress and immune challenges.
How is Rare benign ovarian tumor Diagnosed?
Typical age of diagnosis: Diagnosis typically occurs in women during their reproductive years, often incidentally during imaging for unrelated conditions or during surgery for suspected malignancy.
The clinician looks for symptoms such as pelvic pain or a palpable mass. A detailed history is taken to assess menstrual irregularities and family history of ovarian tumors. Physical examination may reveal an adnexal mass. This step helps determine the need for further diagnostic imaging.
Ultrasound is the primary imaging modality used to evaluate ovarian masses. Specific abnormalities such as solid and cystic components can be visualized. Findings can confirm the diagnosis of a benign tumor and exclude malignancy. MRI may be used to further characterize the lesion and differentiate it from other conditions.
CA-125 and other tumor markers may be ordered to assess for malignancy. Elevated levels can suggest malignancy, but normal levels are common in benign tumors. Abnormal results may prompt further imaging or biopsy. These tests guide the clinician in deciding the urgency and type of intervention.
BRCA1 and BRCA2 genes may be sequenced in cases with a strong family history. Mutations in these genes are typically associated with malignant conditions. Negative results can help confirm a benign diagnosis. Results are crucial for family counseling and assessing future cancer risk.
Rare benign ovarian tumor Treatment Options
Hormonal therapy involves the use of oral contraceptives to regulate menstrual cycles and reduce symptoms. These drugs work by suppressing ovarian function and reducing estrogen levels. Clinical evidence shows efficacy in symptom management but not in tumor size reduction. Limitations include potential side effects like weight gain and mood changes. Long-term use requires monitoring for cardiovascular risks.
Techniques such as biofeedback and manual therapy are used to alleviate pelvic pain. The therapeutic goal is to improve pelvic muscle function and reduce discomfort. Sessions are typically conducted weekly for several months. Measurable outcomes include reduced pain scores and improved quality of life. Long-term benefits include enhanced pelvic stability and function.
Surgery is indicated for symptomatic tumors or when malignancy cannot be excluded. The procedure involves the removal of the tumor while preserving ovarian tissue. Expected benefits include symptom relief and definitive diagnosis. Surgical risks include bleeding and infection. Post-operative care involves pain management and monitoring for complications.
The care team includes gynecologists, radiologists, and genetic counselors. Interventions focus on symptom management and emotional support. Psychosocial support strategies include counseling and support groups. Family education covers disease understanding and management options. Long-term monitoring plans involve regular follow-ups and imaging to assess for recurrence.
When to See a Doctor for Rare benign ovarian tumor
- Severe abdominal pain — this could indicate ovarian torsion or rupture, which requires immediate medical attention.
- Sudden onset of heavy vaginal bleeding — this may signal a complication such as hemorrhage, necessitating urgent care.
- Acute shortness of breath — this could suggest a pulmonary embolism or severe anemia, both of which are emergencies.
- Persistent bloating or abdominal distension — this may indicate tumor growth or fluid accumulation, and a doctor should evaluate it.
- Unexplained weight loss — this can be a sign of underlying pathology, and medical evaluation is recommended.
- Regular menstrual irregularities — these could be related to hormonal imbalances or tumor effects, warranting a doctor's consultation.
- Mild pelvic discomfort — monitor for changes in intensity or frequency and consult a doctor if symptoms worsen.
- Occasional fatigue — track energy levels and ensure adequate rest, consulting a doctor if fatigue persists or worsens.
Rare benign ovarian tumor — Frequently Asked Questions
Is this condition hereditary?
Rare benign ovarian tumors are generally not hereditary and do not follow a specific inheritance pattern. The probability of passing such a tumor to children is extremely low. De novo mutations are not typically associated with these tumors. Carrier status does not apply, as these tumors are not linked to genetic carriers. Genetic counseling is not usually necessary but can be considered for peace of mind.
What is the life expectancy for someone with this condition?
Life expectancy is generally unaffected by rare benign ovarian tumors, as they are non-cancerous. Prognosis is excellent regardless of age of onset, provided complications are managed. Mortality is not typically associated with these tumors unless complications arise. Treatment, such as surgical removal, can improve quality of life and prevent complications. Patients can expect to live a normal lifespan with appropriate management.
How is this condition diagnosed and how long does diagnosis take?
Diagnosis involves imaging studies like ultrasound or MRI, followed by histological examination. The time from first symptoms to diagnosis can vary but often takes several weeks. Gynecologists and radiologists are typically consulted for diagnosis. Delays can occur due to symptom overlap with other conditions or lack of awareness. A biopsy or surgical removal confirms the diagnosis.
Are there any new treatments or clinical trials available?
Current research focuses on minimally invasive surgical techniques and improving diagnostic imaging. Gene therapy is not applicable, but novel approaches in surgical management are promising. ClinicalTrials.gov is a resource for finding relevant trials, and patients should discuss options with their doctor. Inquire about eligibility for trials and potential benefits versus risks. New treatments may become available in the next few years, but current options are effective.
How does this condition affect daily life and activities?
Most individuals experience minimal impact on mobility and self-care once treated. Educational and occupational activities are typically unaffected, though recovery from surgery may require temporary adjustments. Social and emotional challenges can arise from anxiety about health, but support is available. Family burden is usually low, focusing on support during treatment and recovery. Adaptations such as flexible scheduling and emotional support can be beneficial.
Learn More
Support & Resources
References
Content generated with support from peer-reviewed literature via PubMed.
- 1.Ovarian lipoleiomyoma--a rare benign ovarian tumor with pre- and intra-operative features suggestive of malignancy.
Brännström M, Jones I, Lew W et al. · Acta Obstet Gynecol Scand · 2001 · PMID: 11531640
- 2.Ovarian Sclerosing Stromal Tumor. Spectrum of Ultrasound Findings. A Case Report and Review of Literature.
Viesca EL, Claudeville S, Sierra A et al. · J Clin Ultrasound · 2026 · PMID: 41741234
- 3.Signet-ring stromal tumor of the ovary: an extremely rare neoplasm.
Sükür YE, Ozmen B, Atabekoğlu CS et al. · J Turk Ger Gynecol Assoc · 2011 · PMID: 24591961
- 4.Primary ovarian leiomyoma in a premenarchal adolescent: first reported case.
Blue NR, Felix JC, Jaque J · J Pediatr Adolesc Gynecol · 2014 · PMID: 24374195
- 5.Ovarian remnant syndrome with paraintestinal ovarian serous cystadenofibroma arose 30 years after bilateral salpingo-oophorectomy: A case report.
Tien CT, Cheng CH, Ding DC · Medicine (Baltimore) · 2022 · PMID: 36343074
- 6.Laparoscopic management of a twisted ovarian leiomyoma in a woman with 10 weeks' gestation: Case report and literature review.
Kim M · Medicine (Baltimore) · 2016 · PMID: 27858913
- 7.Ovarian cystadenofibroma: A masquerader of malignancy.
Wasnik A, Elsayes K · Indian J Radiol Imaging · 2010 · PMID: 21423907
- 8.Signet-ring stromal tumor of the ovary: clinicopathologic analysis and comparison with Krukenberg tumor.
Vang R, Bagué S, Tavassoli FA et al. · Int J Gynecol Pathol · 2004 · PMID: 14668550
This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.Last reviewed: 2026-05-08